PROPULSID Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Propulsid, and what generic alternatives are available?
Propulsid is a drug marketed by Janssen Pharms and Janssen Pharma and is included in three NDAs.
The generic ingredient in PROPULSID is cisapride monohydrate. There are two drug master file entries for this compound. Additional details are available on the cisapride monohydrate profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for PROPULSID?
- What are the global sales for PROPULSID?
- What is Average Wholesale Price for PROPULSID?
Summary for PROPULSID
US Patents: | 0 |
Applicants: | 2 |
NDAs: | 3 |
Raw Ingredient (Bulk) Api Vendors: | 42 |
Clinical Trials: | 1 |
Patent Applications: | 3,538 |
Formulation / Manufacturing: | see details |
DailyMed Link: | PROPULSID at DailyMed |
![PROPULSID drug patent expirations Drug patent expirations by year for PROPULSID](/p/graph/s/t/PROPULSID-patent-expirations.png)
Recent Clinical Trials for PROPULSID
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Temple University | N/A |
American College of Gastroenterology | N/A |
US Patents and Regulatory Information for PROPULSID
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Janssen Pharms | PROPULSID | cisapride monohydrate | SUSPENSION;ORAL | 020398-001 | Sep 15, 1995 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Janssen Pharma | PROPULSID QUICKSOLV | cisapride monohydrate | TABLET, ORALLY DISINTEGRATING;ORAL | 020767-001 | Nov 7, 1997 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Janssen Pharms | PROPULSID | cisapride monohydrate | TABLET;ORAL | 020210-001 | Jul 29, 1993 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Janssen Pharms | PROPULSID | cisapride monohydrate | TABLET;ORAL | 020210-002 | Dec 23, 1993 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for PROPULSID
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Janssen Pharms | PROPULSID | cisapride monohydrate | SUSPENSION;ORAL | 020398-001 | Sep 15, 1995 | ⤷ Sign Up | ⤷ Sign Up |
Janssen Pharms | PROPULSID | cisapride monohydrate | TABLET;ORAL | 020210-002 | Dec 23, 1993 | ⤷ Sign Up | ⤷ Sign Up |
Janssen Pharms | PROPULSID | cisapride monohydrate | TABLET;ORAL | 020210-001 | Jul 29, 1993 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for PROPULSID
See the table below for patents covering PROPULSID around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Slovenia | 8212190 | Process for preparing N-(4-piperidinyl) benzamides | ⤷ Sign Up |
Japan | S5890552 | NOVEL N-(3-HYDROXY-4-PIPERIDINYL)BENZAMIDE DERIVATIVE | ⤷ Sign Up |
Finland | 78073 | ⤷ Sign Up | |
Croatia | P930478 | PROCESS FOR THE PREPARATION OF N-(4-PIPERIDINYL) BENZANAMIDES | ⤷ Sign Up |
South Africa | 8207194 | ⤷ Sign Up | |
Poland | 138053 | ⤷ Sign Up | |
South Korea | 860001584 | ⤷ Sign Up | |
>Country | >Patent Number | >Title | >Estimated Expiration |
Supplementary Protection Certificates for PROPULSID
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
0076530 | SPC/GB93/037 | United Kingdom | ⤷ Sign Up | |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |